Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 14, 2023

Association of SGLT2 Inhibitor vs DDP4 Inhibitor Use With Risk of Incident OAD Among Patients With Type 2 Diabetes

JAMA Network Open


Additional Info

JAMA Network Open
Association of Sodium-Glucose Cotransporter 2 Inhibitor vs Dipeptidyl Peptidase-4 Inhibitor Use With Risk of Incident Obstructive Airway Disease and Exacerbation Events Among Patients With Type 2 Diabetes in Hong Kong
JAMA Netw Open 2023 Jan 03;6(1)e2251177, PCM Au, KCB Tan, DCL Lam, BMY Cheung, ICK Wong, WC Kwok, CW Sing, CL Cheung

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading